6 results
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
Canagliflozin - Dapagliflozin ... - Empagliflozin ... #pharmacology #table
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
EMPA-REG OUTCOME - Empagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin ... EMPEROR-REDUCED - Empagliflozin ... visualabstract #table
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Canagliflozin • Dapagliflozin ... , empagliflozin ... Pharmacology #summary #table
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
inhibitors that modulate ... canagliflozin (Invokana®), dapagliflozin ... (Farxiga®) and empagliflozin ... canagliflozin, #dapagliflozin ... , #empagliflozin
The Spectrum of Tuberculosis

As shown in the graphic from our Primer, exposure to M. tuberculosis can
graphic from our Primer ... IGRA #Spectrum #Table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
drug to remain stable ... compared to SGLT2 empagliflozin